J. Werringloer

1.9k total citations
35 papers, 1.5k citations indexed

About

J. Werringloer is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, J. Werringloer has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pharmacology and 7 papers in Biochemistry. Recurrent topics in J. Werringloer's work include Pharmacogenetics and Drug Metabolism (13 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). J. Werringloer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). J. Werringloer collaborates with scholars based in United States, Germany and Canada. J. Werringloer's co-authors include R.W. Estabrook, Ronald W. Estabrook, Russell A. Prough, Hartmut Kuthan, N. Chacos, Jorge H. Capdevila, Hiroshi Tsuji, H Graf, Volker Ullrich and B Solymoss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

J. Werringloer

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Werringloer United States 19 710 564 338 261 174 35 1.5k
Kenneth C. Leibman United States 26 753 1.1× 645 1.1× 311 0.9× 226 0.9× 111 0.6× 54 1.8k
Richard T. Okita United States 23 576 0.8× 586 1.0× 435 1.3× 213 0.8× 269 1.5× 51 1.5k
Alvah H. Phillips United States 11 819 1.2× 899 1.6× 313 0.9× 334 1.3× 100 0.6× 16 1.9k
A. H. Conney United States 31 940 1.3× 605 1.1× 221 0.7× 277 1.1× 175 1.0× 56 2.1k
C.‐P. Siegers Germany 26 589 0.8× 492 0.9× 266 0.8× 280 1.1× 113 0.6× 73 2.0k
L R Pohl United States 23 747 1.1× 356 0.6× 211 0.6× 218 0.8× 178 1.0× 42 1.5k
Eugene G. Hrycay Canada 21 762 1.1× 716 1.3× 258 0.8× 245 0.9× 73 0.4× 28 1.7k
Y. Yasukochi Japan 11 931 1.3× 756 1.3× 235 0.7× 403 1.5× 106 0.6× 14 1.6k
Frederick J. Di Carlo United States 16 900 1.3× 473 0.8× 166 0.5× 432 1.7× 191 1.1× 63 1.8k
J.P. Leroux France 22 679 1.0× 842 1.5× 213 0.6× 392 1.5× 107 0.6× 47 1.9k

Countries citing papers authored by J. Werringloer

Since Specialization
Citations

This map shows the geographic impact of J. Werringloer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Werringloer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Werringloer more than expected).

Fields of papers citing papers by J. Werringloer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Werringloer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Werringloer. The network helps show where J. Werringloer may publish in the future.

Co-authorship network of co-authors of J. Werringloer

This figure shows the co-authorship network connecting the top 25 collaborators of J. Werringloer. A scholar is included among the top collaborators of J. Werringloer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Werringloer. J. Werringloer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schrenk, Dieter, et al.. (1991). Immunochemical localization and functional characterization of cytochrome P450IIE1 in rat hepatocyte foci and nodules. Carcinogenesis. 12(12). 2353–2356. 4 indexed citations
2.
Treiber, Gerhard, et al.. (1990). Is cyclosporin A an inhibitor of drug metabolism?. British Journal of Clinical Pharmacology. 30(1). 71–77. 18 indexed citations
3.
Werringloer, J., et al.. (1990). Concomaitant release of nitric oxide and generation of Superoxide during the non-enzymatic decay of SIN-1. European Journal of Pharmacology. 183(4). 1616–1616. 5 indexed citations
4.
Kuthan, Hartmut, et al.. (1986). A spectrophotometric assay for superoxide dismutase activities in crude tissue fractions. Biochemical Journal. 237(1). 175–180. 91 indexed citations
5.
Werringloer, J., et al.. (1985). Oxidative denitrosation and activation of N-nitrosodimethylamine. Biochemical Pharmacology. 34(3). 411–412. 8 indexed citations
6.
Estabrook, R.W., C.A. Martinwixtrom, Y. Saeki, et al.. (1984). The peroxidatic function of liver microsomal cytochrome P-450: Comparison of hydrogen peroxide and NADPH-catalysed iV-demethylation reactions. Xenobiotica. 14(1-2). 87–104. 36 indexed citations
7.
Werringloer, J., et al.. (1982). The reaction of phenylhydrazine with microsomal cytochrome P-450. Catalysis of heme modification.. Journal of Biological Chemistry. 257(8). 4404–4411. 61 indexed citations
8.
Capdevila, Jorge H., N. Chacos, J. Werringloer, Russell A. Prough, & R.W. Estabrook. (1981). Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid.. Proceedings of the National Academy of Sciences. 78(9). 5362–5366. 245 indexed citations
9.
Smilack, Jerry D., et al.. (1980). In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin. Antimicrobial Agents and Chemotherapy. 18(4). 557–561. 34 indexed citations
10.
Kawano, Shin, et al.. (1979). Oxycytochrome P-450: its breakdown to superoxide for the formation of hydrogen peroxide.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2-3). 423–34. 25 indexed citations
11.
Werringloer, J., Shinji Kawano, N. Chacos, & R.W. Estabrook. (1979). The interaction of divalent copper and the microsomal electron transport system. A re-examination of the effects of copper chelates on the function of cytochrome P-450.. Journal of Biological Chemistry. 254(23). 11839–11846. 22 indexed citations
12.
Werringloer, J.. (1978). [29] Assay of formaldehyde generated during microsomal oxidation reactions. Methods in enzymology on CD-ROM/Methods in enzymology. 52. 297–302. 148 indexed citations
13.
Estabrook, R.W., et al.. (1975). Cytochrome P-450: An Oxygenase, Peroxidase and Oxidase. Biochemical Society Transactions. 3(6). 811–813. 8 indexed citations
14.
Matsubara, Takashi, et al.. (1974). Studies on the molecular function of cytochrome P-450 during drug metabolism.. PubMed. 1(1). 98–110. 31 indexed citations
15.
Tuchweber, Béatriz, et al.. (1974). Effect of phenobarbital or pregnenolone-16α-carbonitrile (PCN) pretreatment on acute carbon tetrachloride hepatotoxicity in rats. Biochemical Pharmacology. 23(3). 513–518. 18 indexed citations
16.
Werringloer, J. & Ronald W. Estabrook. (1973). Evidence for an inhibitory product · cytochrome P-450 complex generated during benzphetamine metabolism by liver microsomes. Life Sciences. 13(10). 1319–1330. 39 indexed citations
17.
Tuchweber, Béatriz, et al.. (1973). Ultrastructural changes in rat hepatocytes following discontinuation of pregnenolone-16α-carbonitrile treatment. Cells Tissues Organs. 85(2). 190–205. 2 indexed citations
18.
Solymoss, B, J. Werringloer, & S. Tóth. (1971). The influence of pregnenolone-16α-carbonitrile on hepatic mixed-function oxygenases. Steroids. 17(1-5). 427–433. 49 indexed citations
19.
Solymoss, B, et al.. (1970). SUPPRESSION BY NUCLEIC ACID- AND PROTEIN-SYNTHESIS INHIBITORS OF DRUG DETOXICATION INDUCED BY SPIRONOLACTONE OR ETHYLESTRENOL. Journal of Pharmacology and Experimental Therapeutics. 174(3). 473–477. 9 indexed citations
20.
Solymoss, B, et al.. (1970). Influence of Spironolactone and other Steroids on the Enzymatic Decay and Anticoagulant Activity of Bishydroxycoumarin. Thrombosis and Haemostasis. 23(3). 562–568. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth C. Leibman Breakdown of academic impact, for papers by Richard T. Okita Breakdown of academic impact, for papers by Alvah H. Phillips Breakdown of academic impact, for papers by A. H. Conney Breakdown of academic impact, for papers by C.‐P. Siegers Breakdown of academic impact, for papers by L R Pohl Breakdown of academic impact, for papers by Eugene G. Hrycay Breakdown of academic impact, for papers by Y. Yasukochi Breakdown of academic impact, for papers by Frederick J. Di Carlo Breakdown of academic impact, for papers by J.P. Leroux
Rankless by CCL
2026